News
Wegovy, the groundbreaking GLP-1 obesity medication is now available in South Africa amid growing demand and an evolving ...
More than 40 years ago, Apollonia Kotero met Prince when she auditioned to play his love interest in 1984’s Purple Rain. She ...
Serena Williams has faced speculation of using Ozempic to lose weight, but the tennis legend credits her 31-pound ...
Through innovation, cost discipline, legal action, and competitive pricing, Novo Nordisk has reasserted its leadership in the GLP-1 market. With a robust pipeline and global expansion, NVO is poised ...
1hon MSN
'No Ozempic, just...': Celebrity photographer Joseph Radhik shares weight loss journey at 42
Joseph Radhik, a renowned wedding photographer, shared his three-year fitness journey on Instagram, showcasing his ...
Dr Shazia Malik - a consultant obstetrician and gynaecologist for The Portland Hospital - discussed the pros and cons of ...
A Comeback Fueled by Resilience Danish pharmaceutical giant Novo Nordisk (NYSE:NVO) has been a trailblazer in the GLP-1 drug ...
Tennis star Serena Williams' candor about her GLP-1 use may help dispel the pesky health inaccuracy that weight loss is a ...
Mounjaro and other GLP-1 drugs may lower cancer risk in obese patients, according to a new study. Read more here.
In the wake of weight-loss drugs and the rising importance of health, the iconic cultural brand must double down on its roots ...
Tennis champion Serena Williams said Thursday that she is taking weight loss medication after struggling to see results from diet and exercise following the birth of her two daughters, Olympia and ...
Serena Williams is promoting GLP-1 drugs from Ro.co, which have been met with brutal criticism from many fans.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results